Source:http://linkedlifedata.com/resource/pubmed/id/21151854
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:dateCreated |
2010-12-14
|
| pubmed:abstractText |
Osteoarthritis (OA) is a chronic degenerative joint disease that is a clinically and economically important disease. The increased prevalence of OA with aging, coupled to the demographics of aging populations, make OA a high priority health care problem. Viscosupplementation (VS) is a well-established treatment option in knee OA that is included in the professional guidelines for treatment of this joint disease, and could potentially provide a useful alternative in treating such patients with painful OA. Theoretically VS is an approach that should apply to all synovial joints.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:status |
PubMed-not-MEDLINE
|
| pubmed:issn |
1179-5441
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
3
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
55-68
|
| pubmed:year |
2010
|
| pubmed:articleTitle |
Hylan g-f 20: review of its safety and efficacy in the management of joint pain in osteoarthritis.
|
| pubmed:affiliation |
UOS of Rheumatology, S.Pietro FBF Hospital, Rome, Italy.
|
| pubmed:publicationType |
Journal Article
|